The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation between multiorgan immune-related adverse events and clinical outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC) treated with chemo-immunotherapy.
 
Federico Monaca
No Relationships to Disclose
 
Martin Igor Gomez-Randulfe Rodriguez
No Relationships to Disclose
 
Emanuele Vita
No Relationships to Disclose
 
Antonia Cosmai
No Relationships to Disclose
 
Sara Polidori
No Relationships to Disclose
 
Alessio Stefani
No Relationships to Disclose
 
Guido Horn
No Relationships to Disclose
 
Luca Mastrantoni
No Relationships to Disclose
 
Antonio Vitale
No Relationships to Disclose
 
Jacopo Russo
No Relationships to Disclose
 
Denis Occhipinti
No Relationships to Disclose
 
Alessandro Scala
No Relationships to Disclose
 
Paola Troisi
No Relationships to Disclose
 
Ettore D'Argento
No Relationships to Disclose
 
Mariantonietta Di Salvatore
No Relationships to Disclose
 
Giampaolo Tortora
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Celgene; Dompé Farmaceutici; Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; Roche
 
Raffaele Califano
Stock and Other Ownership Interests - LOC @ TCPC; supportive care UK
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen Oncology; MSD; Pfizer; Roche; Takeda
Consulting or Advisory Role - Janssen; PharmaMar
Speakers' Bureau - Janssen; Takeda
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); MSD (Inst); PharmaMar (Inst); roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Takeda
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche